Melanotan II

Melanotan II is a synthetic cyclic melanocortin analogue studied in pigmentation, melanocortin receptor pharmacology, appetite, autonomic responses, and sexual-function pathways.

Agonizes multiple melanocortin receptors, including MC1R and central melanocortin receptors, producing broad and nonselective signaling.

Limited human investigation with substantial safety concerns.

Level III, Limited human evidence

The compound is not an approved tanning or wellness product. Commercial materials may have uncertain identity and purity.

Reported concerns include nausea, flushing, blood-pressure changes, priapism, pigment changes, sympathomimetic toxicity, and serious neurologic or dermatologic case reports.

No FDA-approved Melanotan II drug product; FDA identifies significant safety concerns.

Supplied strictly for in-vitro and ex-vivo laboratory research. Not for human or veterinary administration, diagnostic, or therapeutic use. Import and regulatory compliance remain the responsibility of the receiving researcher.

Every Cendrix lot ships with an HPLC purity chromatogram, mass-spectrometry identity confirmation, appearance and reconstitution observations, and endotoxin testing where applicable. Lot certificates are retrievable from the Quality page using the lot number printed on the vial.

External searches link to PubMed, ClinicalTrials.gov, Google Scholar, and FDA records. Cendrix does not endorse interpretations published in third-party sources.